Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
HanAll Biopharma Appoints Almira Chabi as Chief Medical Officer and Chief Development Officer 2022-02-21 22:00
Adlai Nortye Announces Publication of Preclinical Research of AN3025 (anti-hTNFR2）in Frontiers in Immunology 2022-02-21 21:00
Harbour BioMed Announces IND Approval for Next-Gen Anti-TSLP Fully Human Monoclonal Antibody 2022-02-21 20:29
Biosion, Inc. Appoints Joel Edwards, MBA, as Chief Business Officer 2022-02-21 13:00
Innovent Announces First Patient Dosing of Universal "Modular" CAR-T Cell product IBI345 2022-02-21 08:00
OliPass Announces Commencement of Dosing in Phase 2a Trial for Pain Killer OLP-1002 2022-02-18 23:00
Keymed Bio Joins Hang Seng Family of Indexes 2022-02-18 22:10
PolyActiva Announces Positive Phase IIa Trial Results in Low Dose Cohort for PA5108 Ocular Implant with Prezia™ Sustained Drug Delivery Technology 2022-02-18 08:19
Gracell Biotechnologies Doses First Patients in First-in-Human Clinical Trial Evaluating GC012F, its Dual-Targeting FasTCAR-T Therapy, in B-Cell Non-Hodgkin's Lymphoma 2022-02-17 21:30
Flat Medical joins the Stay Connected(R), the International Organization for Safer Neuraxial Anesthesia 2022-02-17 21:00
Small Molecule Targeting CD47-SIRPα Pathway: Insilico Medicine Achieves its First Major Milestone in Fosun Pharma Collaboration with the Nomination of Preclinical Candidate for QPCTL 2022-02-17 16:30
BioWorld by Clarivate Provides In-depth Analyses of Long COVID Studies, Potentially the Next Public Health Crisis 2022-02-17 16:00
Kato Wins FDA Approval for Human Studies of Drug for Retinal Disorders 2022-02-17 12:14
CStone Pharmaceuticals Announces the Acceptance of New Drug Application (NDA) for Pralsetinib for the Treatment of RET Fusion-Positive Non-Small Cell Lung Cancer (NSCLC) and RET-Altered Thyroid Cancers in Taiwan, China 2022-02-17 09:19
Innovent Announces Two Registration Studies of IBI306 (anti-PCSK-9 antibody) Met Primary Endpoint 2022-02-17 08:00
PharmaBlock Appoints Dr. Zhengtian Gu as Senior Vice President of Quality and Regulatory Affairs 2022-02-16 20:00
Sirnaomics Receives Safe to Proceed Letter for U.S. FDA Investigational New Drug Application for Systemic RNAi Therapeutic STP707 in Primary Sclerosing Cholangitis (PSC) 2022-02-16 17:04
NIBIOHN, Shionogi Discover Host Immune-dependent Novel Anti-coronavirus Antibody 2022-02-16 14:00
Delos Capital Announces $300 Million First Close of its Third Life Sciences Fund 2022-02-15 23:59
Goodwin Biotechnology Announces the Appointment of Darrin T. Schellin as Chief Executive Officer 2022-02-15 22:35
1 191 192 193 194 195 452